Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,266.85
68 (3.09%)
BSENSE

Jun 18

BSE+NSE Vol: 2.83 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
3.09%
0.33%
1W
7.81%
4.85%
1M
-5.12%
2.78%
YTD
-8.26%
-9.17%
1Y
-30.83%
-4.95%
3Y
59.69%
22.13%
5Y
49.57%
47.89%
10Y
29.05%
190.73%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.6%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.91%
2.41%
-4.5%
6 Months
-11.19%
2.26%
-8.93%
1 Year
-30.83%
1.80%
-29.03%
2 Years
-14.14%
2.60%
-11.54%
3 Years
59.69%
7.12%
66.81%
4 Years
48.93%
8.87%
57.8%
5 Years
49.57%
14.44%
64.01%

Latest dividend: 57 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
-3.87%
4
Quartile
quartile-4
Dec-Mar
-7.59%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
YTD
-33.03%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
-3.87%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
Sep-Dec
-6.99%
4
Quartile
quartile-4
YTD
-33.03%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
-3.87%
2
Quartile
quartile-2
Dec-Mar
-7.59%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
YTD
-33.03%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available